Hbgrace XT Tablet is a pharmaceutical formulation combining Ferrous Ascorbate 100 mg and Folic Acid 1.5 mg, designed to effectively manage and prevent iron deficiency anemia and folate deficiency. Ferrous Ascorbate, a bioavailable form of iron, facilitates the replenishment of iron stores in the body, essential for hemoglobin synthesis and oxygen transport. Concurrently, Folic Acid plays a critical role in DNA synthesis and red blood cell formation, thereby supporting hematopoiesis and preventing megaloblastic anemia. This combination is particularly beneficial in conditions associated with increased iron and folate requirements such as pregnancy, lactation, chronic blood loss, and nutritional deficiencies. Hbgrace XT Tablet aids in improving clinical symptoms like fatigue, pallor, and weakness by restoring adequate hemoglobin levels and promoting overall hematologic health. It is recommended to be administered under medical supervision, with dosage tailored according to individual patient needs and severity of deficiency. Caution is advised in patients with hypersensitivity to any component, hemochromatosis, or other iron overload disorders. Regular monitoring of hemoglobin and serum ferritin levels is essential to evaluate therapeutic response and avoid potential adverse effects. Hbgrace XT Tablet is a valuable therapeutic agent in the comprehensive management of anemia related to iron and folate deficiencies.